Saratoga Research & Investment Management
Q4 2025 13F Holdings
- Locationsaratoga, CA
- Num holdings
47
- Value ($000)
$1,907,744
- Date Filed02/05/2026
- Form type13F-HR
- CIK0001477872
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
Alphabet Inc. CAP STK CL A | COM | 02079K305 | $225.31M | 12 % | 719,847 | ||
Microsoft Corp. | COM | 594918104 | $144.46M | 8 % | 298,708 | ||
Berkshire Hathaway Inc. CL B NEW | COM | 084670702 | $132.33M | 7 % | 263,262 | ||
Unilever PLC SPON ADR NEW | COM | 904767803 | $121.19M | 6 % | 1,853,095 | ||
Walt Disney Company | COM | 254687106 | $116.48M | 6 % | 1,023,783 | ||
Medtronic PLC | COM | G5960L103 | $110.96M | 6 % | 1,155,146 | ||
Johnson & Johnson | COM | 478160104 | $95.24M | 5 % | 460,223 | ||
Roche Holding AG SPONSORED ADR | COM | 771195104 | $94.52M | 5 % | 1,832,770 | ||
Novo Nordisk A/S ADR | COM | 670100205 | $94.26M | 5 % | 1,852,566 | ||
ASML Holding N.V. | COM | N07059210 | $75.14M | 4 % | 70,236 |
Rows Per Page
10
- 5
- 10
- 20
- 30
- 50
- 100